يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Iordanis Arzimanoglou"', وقت الاستعلام: 0.29s تنقيح النتائج
  1. 1
    European Innovation Council's strategic actions: A game-changer for cell and gene therapy

    المؤلفون: Iordanis Arzimanoglou

    المصدر: Mol Ther

    مصطلحات موضوعية: Pharmacology, Europe, Editorial, Drug Discovery, Genetics, Molecular Medicine, Humans, Genetic Therapy, Molecular Biology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f829e2b837fed94f17aa772362d607e
    https://pubmed.ncbi.nlm.nih.gov/35417666

    View record in OpenAIRE

    أضف إلى المفضلة
  2. 2
    Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients

    المؤلفون: George Fountzilas, Smaragda Kamakari, Irene Konstantopoulou, Angela Ladopoulou, George Nikolopoulos, Evangelia Razis, Iordanis Arzimanoglou, Theodore Anagnostopoulos, Christos Markopoulos, Thalia Bei, Nikos Pandis, Drakoulis Yannoukakos, Helen Gogas, George Nounesis, Sophia Armaou, Charisios Karanikiotis, Theodore Rampias, Antonios Keramopoulos, George Koutsodontis, Antonis Stylianakis, Dimosthenis Skarlos, Vassiliki Gaki

    المصدر: Breast cancer research and treatment. 107(3)

    مصطلحات موضوعية: Cancer Research, endocrine system diseases, Cost-Benefit Analysis, Genes, BRCA2, Genes, BRCA1, Breast Neoplasms, Biology, Germline, Germline mutation, Breast cancer, medicine, Humans, skin and connective tissue diseases, Genetic testing, Genetics, Ovarian Neoplasms, medicine.diagnostic_test, Greece, Cancer, medicine.disease, Oncology, Mutation (genetic algorithm), Mutation, Mutation testing, Female, Ovarian cancer

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e5d40ad4a5fb8578db107202d1595c
    https://pubmed.ncbi.nlm.nih.gov/17453335

    View record in OpenAIRE

    أضف إلى المفضلة
  3. 3
    Academic Journal
    EPIDEMIOLOGY Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1

    المؤلفون: Nikos Pandis, Æ Thalia Bei, Æ Iordanis Arzimanoglou, Æ George Fountzilas, Æ Drakoulis Yannoukakos, I. Konstantopoulou, A. Ladopoulou, S. Armaou, T. Anagnostopoulos, G. Nikolopoulos, G. Nounesis, D. Yannoukakos, T. Rampias, G. Koutsodontis, S. Kamakari, T. Bei, A. Stylianakis, C. Karanikiotis, E. Razis, H. Gogas

    المساهمون: The Pennsylvania State University CiteSeerX Archives

    المصدر: http://www.rrp.demokritos.gr/rrp2/file/Konstantopoulou et al 2008.pdf.

    وصف الملف: application/pdf

    Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.518.2135; http://www.rrp.demokritos.gr/rrp2/file/Konstantopoulou et al 2008.pdf

    الاتاحة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.518.2135
    http://www.rrp.demokritos.gr/rrp2/file/Konstantopoulou et al 2008.pdf

    View record in BASE

    أضف إلى المفضلة
  4. 4
    Academic Journal
    Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.

    المؤلفون: Theodore Rampias, George Koutsodontis, Sophia Armaou, Theodore Anagnostopoulos, George Nikolopoulos, Smaragda Kamakari, George Nounesis, Antonis Stylianakis, Charisios Karanikiotis, Evangelia Razis, Helen Gogas, Antonios Keramopoulos, Vassiliki Gaki, Christos Markopoulos, Dimosthenis Skarlos, Nikos Pandis, Thalia Bei, Iordanis Arzimanoglou, Drakoulis Yannoukakos

    المصدر: Breast Cancer Research & Treatment; Feb2008, Vol. 107 Issue 3, p431-441, 11p, 1 Diagram, 3 Charts, 1 Graph

    مصطلحات موضوعية: CANCER patients, GENETIC mutation, BREAST cancer, PUBLIC health


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء